In vitro release of arachidonic acid metabolites, glutathione peroxidase, and oxygen-free radicals from platelets of asthmatic patients with and without aspirin intolerance

Vicente Plaza, Jordi Prat, Joan Rosello, Eugeni Ballester, Isabel Ramis, Joaquim Mullol, Emilio Gelpi, Josep L.L. Vives-Corrons, Cesar Picado*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

25 Citations (Scopus)


Background - An abnormal platelet release of oxygen-free radicals has been described in acetylsalicylic acid (aspirin)- induced asthma, a finding which might suggest the existence of an intrinsic, specific platelet abnormality of arachidonic acid metabolism in these patients. The objective of this study was to evaluate platelet arachidonic acid metabolism in asthmatic patients with or without intolerance to aspirin. Methods - Thirty subjects distributed into three groups were studied: group 1, 10 healthy subjects; group 2, 10 asthmatic patients with aspirin tolerance; and group 3, 10 aspirin-intolerant asthmatics. Platelets were isolated from blood, preincubated with 3H-arachidonic acid for 30 minutes and then incubated for 10minutes with platelet activating factor (PAF) and aspirin. Cyclo-oxygenase (thromboxane, PGE2, PGF, and HHT) and lipoxygenase (12-HETE) arachidonic acid metabolites were measured by high pressure liquid chromatography. Release of oxygen free radicals after incubation with PAF and aspirin was measured by chemiluminescence. Platelet levels of glutathione peroxidase (GSH-Px) were also measured using spectrophotometry. Results - Platelets from aspirin-intolerant asthmatic patients produced higher quantities of arachidonic acid metabolites than the control group at baseline conditions. This increase was significant only for lipoxygenase products. No differences were found amongst the three groups in the response of arachidonic acid metabolism to PAF and aspirin. Incubation with aspirin but not with PAF caused an increase in oxygen-free radical production in aspirin-intolerant patients whereas in aspirin-tolerant patients PAF, rather than aspirin, was the more potent stimulus for oxygen-free radical production. No differences in GSH-Px levels were found amongst the three groups. Conclusions - These results suggest that the platelet lipoxygenase pathway is activated in aspirin-intolerant patients and that the production ofoxygen-free radicals may differentiate aspirin-tolerant from aspirin- intolerant asthmatic subjects. Our study, however, does not support the hypothesis that an increase in lipoxygenase products may be responsible for oxygenfree radical production. Moreover, a lowered platelet GSH-Px activity does not seem to be involved in this phenomenon.

Original languageEnglish
Pages (from-to)490-496
Number of pages7
Issue number5
Publication statusPublished - 1995


  • Arachidonic acid metabolites
  • Aspirin-sensitive asthma
  • Bronchial asthma
  • Glutathione peroxidase
  • Oxygen-free radicals


Dive into the research topics of 'In vitro release of arachidonic acid metabolites, glutathione peroxidase, and oxygen-free radicals from platelets of asthmatic patients with and without aspirin intolerance'. Together they form a unique fingerprint.

Cite this